Consumer Advocates Step Up and Submit Comments to FDA Regarding Regulation of Social Media
The deadline has come and gone for submitting comments to docket FDA-2009-N-0441 regarding "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media...
According to Follower Wonk, I Have More Followers in Common with Pfizer Than Other...
This morning I learned about "Follower Wonk," a neat Twitter application that creates Venn diagrams showing the overlap among followers of up to three...
Where’s Your Social Media Crisis Management Plan?
According to Chris Kenton of SmartMarketers.com's Inspire Blog, "Surprisingly few companies... have protocols in place to manage social media disasters as they unfold --...
Drug Companies Are Flocking to Facebook for Eyeballs, Not Conversation
More and more pharmaceutical companies are launching Facebook pages that promote their products. The latest is Allergan, which launched a celebrity Facebook campaign for...
Johnson & Johnson Urges FDA to Be As Flexible As FTC in Its Regulation...
In comments to the FDA, Johnson & Johnson (JNJ) stated "Flexibility in regulatory approach is crucial in the evolving digital world." The comment was...
Novartis Proposes Use of Unique FDA-Approved Short URLs & Hashtags to Overcome Space Limitation...
Novartis submitted 6 pages of comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find...
Should Sanofi-Aventis Submit an Adverse Event Report Based on “Disgruntled Patient’s” Comments to VOICES...
Sanofi-Aventis (S-A) submitted 14 pages of comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools...
Sanofi-Aventis Updates Facebook Site with Disclaimer, But Shirley Still Posting About Her Side Effects
Recently, Sanofi-Aventis has been having problems with its VOICES Facebook page (see "Disgruntled Patient Shuts Down sanofi-aventis Facebook Page"). I previously suggested S-A made...
Yahoo!’s Claim That Patients Are “Ambivalent” When It Comes to Side Effect Information in...
Yahoo! submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).
In defense...
Use of Internet to Obtain Health Information Can Make You Depressed
FDA is considering issuing new guidelines regarding regulation of pharmaceutical use of the Internet for promoting drugs. The drug industry and online service providers...
